{"disease":{"id":"cd19-expressing-malignancies","name":"cd19 expressing malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04649112","title":"Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Precision BioSciences, Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}